fieramilanocity, 25 - 28 ottobre 2010 :
Download

Iscriviti alla newsletter

Sign up for the newsletter

Biotech's promises for the future: turning challenges into opportunities

LOCATION: FieraMilanoCity. The Room of each Conferences Sessions is mentioned within the following programme.

ENTRANCE: The access to the Conference is free, upon payment of the Fair ticket (except 25th of October).


PARTICIPATION: Participants are adviced to report to the Conference reception desk well in advance; at least, 20 minutes before the start of the session.

LANGUAGE: Unless otherwise specified, Conference Presentations will be in English; simultaneous translation will not be provided.


* to be confirmed

Tuesday, 26 October 2010

Bolaffio room, hall 1. This session will be held in Italian
10.30-11.30 Welcome and opening address

11.30-13.00 

Roundtable
The role of Charities and Bank Foundations in boosting public and private investment in R&D

Chairs: Alessandro Sidoli (ASSOBIOTEC)
Massimo Boriero (Farmindustria)

 

Panelists:
Niccolò Contucci (AIRC)

 

Francesca Pasinelli (Telethon)

 

Carlo Mango (Fondazione Cariplo)

 

Mario Alberto Battaglia (FISM)

Oro room, hall 1. This session will be held in Italian - Sponsored by Assogenerici
14.00-16.00 I farmaci biologici e biosimilari: normative, utilizzo, sicurezza
Chair: Leonardo Santi (Comitato Nazionale per la Biosicurezza e Biotecnologie)

14.00-14.10 

Apertura dei lavori e introduzione a cura del Chair
Leonardo Santi (Comitato Nazionale per la Biosicurezza e Biotecnologie)

14.10-14.30 

Le risposte terapeutiche: la posizione della scienza
da definire*

14.30-14.50 

Normativa internazionale
da definire*

1514.50-15.10 

Bandi di gara e procedure d'acquisto
Stefano Cencetti (Azienda Ospedaliera - Policlinico di Modena)
Maurizio Miselli (Azienda Ospedaliera - Policlinico di Modena)

15.10-16.00 

La posizione delle aziende
Assobiotec-Maurizio Guidi (Eli Lilly)
Assogenerici-Manlio Florenzano (Sandoz)

Oro room, hall 1
16.30-18.00 Company presentations

Wednesday, 27 October 2010

Oro room, hall 1. Session sponsored by Società Italiana Brevetti
10.00-11.00 The role of intellectual property in biotech
Chair: to be defined*

10.00-10.15 

European legislation
speaker to be defined*

10.15-10.35 

Legal aspects in the protection of biotechnology inventions


Claudio Germinario (Società Italiana Brevetti)

10.35-10.50 

Technology transfer and technology development at IFOM and IEO: the TTFactor Srl model
Daniela Bellomo (IFOM - IEO)

10.50-11.00  

Question Time

Oro room, hall 1. Organized in cooperation with AIFI - Italian Association of Private Equity and Venture Capital. Sponsored by PriceWaterhouseCoopers
11.00-13.00 Biotech Start up Challenge
Competition to identify top technologies, products, services start up

Chair: Marco Tanzi Marlotti (PriceWaterhouseCoopers)
Argento room, hall 1 Session sponsored by bioMérieux Italia SpA
10.00-11.20 Roundtable: Advanced Therapies: where are the opportunities?
Chair: Cristina Pintus (AIFA)

 

Panelists:
Paolo Rebulla (Fondazione Ca' Granda Ospedale Maggiore Policlinico di Milano)

 

Mauro Picardo (Istituto Dermatologico San Gallicano Roma)

 

Marco Dieci (Molmed SpA)

 

Giorgio Prina (bioMérieux Italia SpA)

 

Riccardo Pietrabissa (Politecnico di Milano)

Argento room, hall 1
11.30-13.00 Nanotechnologies for the biotech industry
Chair: Fabrizio Pirri (Politecnico di Torino)

11.30-11.40 

Welcome and opening address
Fabrizio Pirri (Politecnico di Torino)

11.40-11.55 

Micro and nanotechnologies for biomolecular detection
Fabrizio Pirri (Politecnico di Torino)

11.55-12.10 

Advancing applied and fundamental neurophysiology with micro-/nano-structured neuroelectronic devices
Luca Berdondini (Istituto Italiano di Tecnologie)

12.10-12.25 

Nanoparticles for Drug-Delivery
Francesco Stellacci (Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, The Italian National Neurological Institute "Carlo Besta" (INCB), Milan, European Centre for Nanomedicine (CEN), Milan)

Oro room, hall 1

14.00-15.20 Neurodegeneration: progresses and challenges
Oro room, Hall 1. In collaboration with Innovhub - Promos
15.30-17.20 International collaborations in the biotech sector: overview on the European projects in the region. What benefits for industry and research?
Chair: to be defined*

15.30-15.40 

Welcome and opening address

15.40-16.00 

Trasnational cluster network in the biotech and medtech sector at Alpine level. The experience of the Alps Bio Cluster project
Mara Tumiati (Innovhub/Milan Chamber of Commerce)

16.00-16.20 

Advanced Biotech Cluster platform for Europe: cluster efforts to create more efficient support services for bio companies
Mara Tumiati (Innovhub/Milan Chamber of Commerce)

16.20-16.40 

Focused collaborations with emerging countries. When Europe meets India with the European Business and Technology Centre
Gianpaolo Sarolli (Innovhub/Milan Chamber of Commerce)

16.40-17.00 

Added value services for biotech operators across Europe and beyond: the Enterprise Europe Network
Susy Longoni (Innovhub/Milan Chamber of Commerce)

17.00-17.10 

Question Time

17.10-17.20 

Conclusions and closure of the session by the Chair

Argento room, hall 1. Sponsored by Astra Zeneca
14.00-15.15 The evolution of oncology drug development
Chair: Maria Grazia Daidone (Istituto Nazionale dei Tumori)

14.00-14.10 

Welcome and opening address by the Chair
Maria Grazia Daidone (Istituto Nazionale dei Tumori)

14.10-14.25 

Membrane-bound TRAIL as an anticancer agent: preclinical experience and clinical programs at Istituto Nazionale dei Tumori
Carmelo Carlo Stella (Fondazione IRCCS - Istituto Nazionale dei Tumori)

14.25-14.40 

From bench to bedside: Vandetanib(Zactima), an orphan drug for the treatment of advanced medullary thyroid carcinoma
speaker to be defined (Astra Zeneca)

Argento room, hall 1
15.30-17.30 Bioengineering, an emerging avenue in regenerative medicine
Chair: Laura Teodori (BAS BIOTEC-MED, ENEA)

15.30-15.40 

Welcome and opening address

15.40-16.00 

Smart technologies for regeneration of bone and cartilage
Daniele Pressato (Finceramica SpA)

16.00-16.20 

Bioreactors in Regenerative Medicine: from the bench to the bedside
Stefania A. Riboldi (SKE Advanced Therapies)

16.20-16.40 

Tissue engineering in orthopedic surgery : clinical applications

Milena Fini (Istituto Ortopedico Rizzoli di Bologna)

16.40-17.00 

Tissue engineering technologies in cardiovascular medicine
Stefano De Porcellinis (Biomatica)

17.00-17.20 

Tissue Engineering and Heart Mending
Paolo Di Nardo (Syntech Srl)

17.20-17.30  

Conclusion and closure of the session by the chair
Laura Teodori (BAS BIOTEC-MED, ENEA)

Thursday, 28 October 2010

Oro room, hall 1. In collaboration with Assobiotec
10.00-12.50 Biotechnology and the new challenges of the nutritional research
Chair: Gianluca Carenzo (Parco Tecnologico Padano)

10.00-10.10 

Welcome and opening address
Gianluca Carenzo (Parco Tecnologico Padano)

10.10-10.40 

The new challenges of the nutritional research
Marisa Porrini (Università di Milano, SINU)

10.40-11.10 

Nutrilipidomics: starting from cell membrane
Carla Ferreri (Lipinutragen)

11.10-11.45 

Research, development and production of functional foods
Anna Arnoldi (HPF Nutraceutics)
Elisabetta Agradi (Phytoremedial)
Sebastiano Banni (Nutrisearch)
Elena Sgaravatti (IRB)

11.45-12.30 

Food Industry and functional foods
Nestlé Italia
Danone Italia*

12.30-12.40 

Question Time

12.40-12.50 

Conclusion and closure of the session by the Chair

Gianluca Carenzo (Parco Tecnologico Padano)

Argento room, hall 1
10.00-11.30 Where is white biotechnology going?
Chair: Aurelio Viglia (AIDIC)

10.00-10.10 

Welcome and opening address
Aurelio Viglia (AIDIC)

10.10-10.30 

Industrial biotechnology and beyond biofuels. US and global business clusters and investments trends
Paolo Barbanti, Pharma & Biotech Advisors srl

10.30-10.50 

Energy (and More) from Microalgae: opportunities, issues and possible developments scenarios
Marco Bravi (Università di Roma La Sapienza)

10.50-11.10 

Use of enzymes in API synthesis: two examples
Riccardo Motterle, FIS, (Fabbrica Italiana Sintetici)

11.10-11-30 

Biotransformation of Plant Active Intermediates
Cesare Ponzone (Indena)

Argento room, hall 1
11.30-13.00 The future of orphan drugs

Chair: to be defined*

00:00-00:00 

The Biotech Industry for the Rare Diseases
Roberto Lorè (Assobiotec, Biomarin Europe Ltd)

Programma conferenze 2010

NUCE InternationalNUCE International

BiotechBiotech

Algae EuropeAlgae Europe